__NUXT_JSONP__("/drugs/Xiliertinib", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"1353644-70-8",chebiId:b,chemicalFormula:b,definition:"An orally available, ATP-competitive inhibitor of the epidermal growth factor receptor (EGFR), with potential antineoplastic activity. Upon oral administration, xiliertinib binds to and inhibits the activity of EGFR. This prevents EGFR-mediated signaling, and may lead to both induction of cell death and inhibition of tumor growth in EGFR-overexpressing cells. EGFR, a receptor tyrosine kinase mutated in many tumor cell types, plays a key role in tumor cell proliferation and tumor vascularization.",fdaUniiCode:"6ZZ3B7NZ0B",identifier:"C162552",preferredName:a,semanticType:"Pharmacologic Substance",subclassOf:["C129825","C2167"],synonyms:["HMPL 309","HMPL-309","HMPL309","Theliatinib","XILIERTINIB",a]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FXiliertinib",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Xiliertinib","","2021-10-30T13:35:24.713Z")));